. It has been previously demonstrated that mouse dendritic cells deficient in scavenger receptor A (SRA) negatively regulated the immune response produced by Toll-like receptors when exposed to modified lipid proteins. Previously, we have shown that peptidoglycan contained in organic dust from swine barns stimulates pro-inflammatory cytokine release in bronchial epithelium. We hypothesized bronchial epithelial SRA would also have a regulatory role in the cytokine response produced by toll-like receptors. METHODS/MATERIALS: Primary and immortalized (Beas-2B) human bronchial epithelial cells were grown in serum-free media to 70% confluency. Cells were incubated with 100 100 100 μg/ml fucoidan (a known SRA ligand), μg/ml fetuin (a negative control for SRA), and μg/ml chondroitan sulfate (a known SRB ligand) for 24 hours. Each sample was then incubated with 10 μg/ml of peptidoglycan or media for 24 and 48 hours. The media was then collected and assayed for IL-8 using a standard sandwich ELISA.
IL-8 production was significantly increased in cells pre-treated with fucoidan followed by peptidoglycan as compared to either RESULTS: media control (3-fold increase) or peptidoglycan only (2-fold increase). Cells treated with fucoidan, fetuin, or chondroitin sulfate demonstrated no significant increase in IL-8 production vs. media control. Cells pre-treated with fetuin or chondroitin sulfate followed by peptidoglycan produced no enhanced increase in IL-8 production when compared to peptidoglycan alone. CONCLUSIONS: These data show that peptidoglycan can stimulate IL-8 production maximally at 24 hours. When human bronchial epithelium is first treated with a SRA ligand, fucoidan, IL-8 release is increased. Increased production of IL-8 by bronchial epithelium under these conditions suggests that SRA has a co-stimulatory relationship with TLR-2. These results suggest that receptor crosstalk may have a role in the airway inflammatory response to inhaled Gram-positive bacteria.
